Trial Profile
A Randomized, Open Label, Single Dose, Cross-over, Phase I Trial to Investigate Safety and Pharmacokinetics of DW-ES(B) and Megace Under Fasting and Fed Conditions in Healthy Male Volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Megestrol (Primary)
- Indications Anorexia; Cachexia
- Focus Adverse reactions
- 26 Oct 2011 New trial record